Morgan Keegan reports that its EPS estimate of $0.72 is the only published estimate and is up from $0.60 in the prior year period.
“We continue to view the favorable RUG-IV Medicare rates as a driver to strong earnings growth in 2011 that could exceed our estimates,” Morgan Keegan writes.
“National Healthcare Corp. NHC also offers investors a strong balance sheet and a 2.4% dividend yield. NHC realized a nearly 16% sequential increase in its Medicare per diem during the fourth quarter and we expect further improvement, barring any cuts that the Centers for Medicare & Medicaid Services may propose in coming days.”
National Healthcare closed Thursday at $46.24.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in